Komipharm is trading at 17,200 KRW as of 10:30 AM on the 29th, down 0.29% from the previous day. This represents an 8.99% decline compared to June 2. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Today, foreigners are tentatively recorded as net buyers of 11,269 shares. Over the past five days, individual investors have net purchased 235,086 shares, while foreigners and institutions have net sold 214,167 shares and 33,165 shares, respectively.

On June 25, Komipharm became a market topic with the headline "Rise on COVID-19 Treatment Clinical Trial Application."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing